Heilongjiang Key Laboratory of Anti-fibrosis Biotherapy, College of Life Sciences, Mudanjiang Medicai University, Mudanjiang, China.
Department of Burns and Plastic Surgery, Shanghai Changzheng Hospital, Shanghai, China.
Mini Rev Med Chem. 2023;23(15):1535-1559. doi: 10.2174/1389557523666230203145645.
Tumors are a major cause of human mortality worldwide, and the rapid development of nanomaterials (NMs) for tumor therapy and drug delivery has provided new treatment methods. However, NMs' high immunogenicity, short circulation time, and low specificity limit their application in tumor therapy. In recent years, bionanomaterials using cell membranes have emerged to overcome the shortcomings of monomeric NMs. Cell membrane-encapsulated NMs extracted from multiple cells not only retain the physicochemical properties of NMs but also inherit the biological functions of the source cells, aiding in drug delivery. The combination of the cell membrane and drug-loading NMs offers an efficient and targeted drug delivery system tailored to the tumor microenvironment. The research and application of this method have been widely carried out in the academic field of tumor diagnosis and treatment. This review presents the recent research progress of cell membrane-coated NMs as drug carriers in tumor therapy, including cell membrane extraction methods, encapsulation strategies, and the applications of cell membrane-encapsulated NMs in tumor therapy. We believe that biomimetic nanomaterials will be a promising and novel anticancer strategy in the future, and their wide application will certainly bring vitality to the field of tumor diagnosis and treatment. The combination of membrane and drug-loading nanomaterials embodies a highly efficient and target drug delivery system tailored to the tumor microenvironment, which broadens a new path of drug delivery for future cancer treatment. Meanwhile, it is also a perfect combination and application of biomedical nanomaterials, which is of great significance.
肿瘤是全球范围内导致人类死亡的主要原因,而纳米材料(NMs)在肿瘤治疗和药物输送方面的快速发展为提供了新的治疗方法。然而,NMs 的高免疫原性、短循环时间和低特异性限制了它们在肿瘤治疗中的应用。近年来,利用细胞膜的生物纳米材料已经出现,以克服单体 NMs 的缺点。从多种细胞中提取的细胞膜包裹的纳米材料不仅保留了 NMs 的物理化学性质,还继承了源细胞的生物学功能,有助于药物输送。细胞膜和载药纳米材料的结合提供了一种针对肿瘤微环境的高效和靶向药物输送系统。这种方法的研究和应用在肿瘤诊断和治疗的学术领域得到了广泛的开展。本文综述了细胞膜包裹的纳米药物载体在肿瘤治疗中的最新研究进展,包括细胞膜的提取方法、包裹策略,以及细胞膜包裹的纳米材料在肿瘤治疗中的应用。我们相信仿生纳米材料将是未来一种有前途和新颖的抗癌策略,它们的广泛应用必将为肿瘤诊断和治疗领域带来活力。膜和载药纳米材料的结合体现了一种针对肿瘤微环境的高效和靶向药物输送系统,为未来癌症治疗开辟了新的药物输送途径。同时,这也是对生物医学纳米材料的完美结合和应用,具有重要意义。